Featured Article
News
10/10/2024
Lisa Kuhns, PhD, MD
Combining pembrolizumab with radiotherapy significantly enhances overall survival (OS) in patients with metastatic urothelial carcinoma (mUC) who have progressed after platinum-based chemotherapy, according to results from the ARON-2...
Combining pembrolizumab with radiotherapy significantly enhances overall survival (OS) in patients with metastatic urothelial carcinoma (mUC) who have progressed after platinum-based chemotherapy, according to results from the ARON-2...
Combining pembrolizumab with...
10/10/2024
Veterans Health Today
News
09/10/2024
Lisa Kuhns, PhD, MD
Adjuvant chemotherapy significantly improves disease-free survival (DFS) for patients with muscle-invasive upper tract urothelial cancer (UTUC), according to study results published in the Journal of Clinical Oncology.
Adjuvant chemotherapy significantly improves disease-free survival (DFS) for patients with muscle-invasive upper tract urothelial cancer (UTUC), according to study results published in the Journal of Clinical Oncology.
Adjuvant chemotherapy...
09/10/2024
Veterans Health Today
News
08/07/2024
Lisa Kuhns, PhD, MD
Bladder LCNEC is rare and aggressive and needs early diagnosis and comprehensive care.
Bladder LCNEC is rare and aggressive and needs early diagnosis and comprehensive care.
Bladder LCNEC is rare and...
08/07/2024
Veterans Health Today
News
02/29/2024
Allison Casey
Final, updated results from the phase 3 POUT trial added further support to the use of adjuvant chemotherapy for patients with upper tract urothelial cancer who have undergone nephroureterectomy.
Final, updated results from the phase 3 POUT trial added further support to the use of adjuvant chemotherapy for patients with upper tract urothelial cancer who have undergone nephroureterectomy.
Final, updated results from the...
02/29/2024
Oncology
From Oncology
Quiz
09/15/2022
Maria Asimopoulos
Bladder cancer is the fourth most common type of cancer in US veterans. Among patients with upper tract urothelial carcinoma, how prevalent are low-grade cases?
Bladder cancer is the fourth most common type of cancer in US veterans. Among patients with upper tract urothelial carcinoma, how prevalent are low-grade cases?
Bladder cancer is the fourth...
09/15/2022
Veterans Health Today